ProShare Advisors LLC Grows Position in Healthpeak Properties, Inc. (NYSE:DOC)

ProShare Advisors LLC boosted its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 29.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 176,001 shares of the real estate investment trust's stock after acquiring an additional 40,432 shares during the quarter. ProShare Advisors LLC's holdings in Healthpeak Properties were worth $3,568,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Barclays PLC bought a new position in Healthpeak Properties during the third quarter worth about $35,078,000. JPMorgan Chase & Co. lifted its position in shares of Healthpeak Properties by 23.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock valued at $493,115,000 after acquiring an additional 4,056,931 shares during the period. Assenagon Asset Management S.A. raised its holdings in shares of Healthpeak Properties by 18.0% during the 4th quarter. Assenagon Asset Management S.A. now owns 29,143 shares of the real estate investment trust's stock worth $591,000 after buying an additional 4,446 shares in the last quarter. Park Avenue Securities LLC increased its holdings in Healthpeak Properties by 11.6% in the 4th quarter. Park Avenue Securities LLC now owns 24,700 shares of the real estate investment trust's stock worth $501,000 after purchasing an additional 2,567 shares in the last quarter. Finally, Merit Financial Group LLC acquired a new position in Healthpeak Properties in the 4th quarter worth about $506,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

DOC has been the topic of several recent research reports. Evercore ISI cut their price target on Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Wedbush dropped their price target on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Robert W. Baird decreased their target price on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Tuesday, April 29th. Wall Street Zen cut Healthpeak Properties from a "hold" rating to a "sell" rating in a research report on Thursday, May 1st. Finally, Argus restated a "buy" rating and set a $25.00 target price on shares of Healthpeak Properties in a research report on Tuesday, April 29th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $23.45.

Healthpeak Properties Stock Up 0.2%

NYSE:DOC traded up $0.04 during midday trading on Friday, hitting $16.86. 5,878,293 shares of the company were exchanged, compared to its average volume of 5,080,581. The company has a fifty day simple moving average of $18.46 and a 200 day simple moving average of $19.86. Healthpeak Properties, Inc. has a fifty-two week low of $16.64 and a fifty-two week high of $23.26. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. The company has a market capitalization of $11.71 billion, a PE ratio of 48.17, a price-to-earnings-growth ratio of 2.17 and a beta of 1.05.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting analysts' consensus estimates of $0.46. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The firm had revenue of $702.89 million for the quarter, compared to the consensus estimate of $690.76 million. During the same quarter in the previous year, the firm earned $0.45 earnings per share. The firm's revenue was up 15.9% on a year-over-year basis. As a group, equities analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently disclosed a dividend, which will be paid on Friday, May 30th. Shareholders of record on Tuesday, May 20th will be issued a dividend of $0.1017 per share. This represents a yield of 7.05%. The ex-dividend date is Monday, May 19th. Healthpeak Properties's dividend payout ratio is currently 305.00%.

Insider Activity

In other Healthpeak Properties news, Director Tommy G. Thompson bought 5,700 shares of Healthpeak Properties stock in a transaction on Friday, May 9th. The stock was purchased at an average cost of $17.36 per share, for a total transaction of $98,952.00. Following the completion of the purchase, the director now directly owns 138,513 shares of the company's stock, valued at $2,404,585.68. The trade was a 4.29% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director John T. Thomas bought 4,200 shares of the business's stock in a transaction that occurred on Monday, April 28th. The shares were bought at an average price of $17.84 per share, with a total value of $74,928.00. Following the completion of the purchase, the director now owns 813,566 shares in the company, valued at approximately $14,514,017.44. The trade was a 0.52% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders acquired 23,987 shares of company stock valued at $422,141. Company insiders own 0.23% of the company's stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.